Biopharmaceutical Company

Lycera Achieves First Milestone in Merck Research CollaborationLycera Corp., a biopharmaceutical company creating innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has reached the first milestone under its research collaboration with Merck, triggering a milestone payment.
Holiday Drinks: Jazz Up Your Eggnog!
Becoming A Storm Trooper For Charity

Watch & Listen